Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Parkinson disease and growth factors — is GDNF good enough?
Agnete Kirkeby
*
, Roger A. Barker
*
Corresponding author for this work
Laboratory
12
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Parkinson disease and growth factors — is GDNF good enough?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glial Cell Line-derived Neurotrophic Factor
100%
Growth Factors
100%
Disease Factor
100%
Parkinson's Disease
100%
Good Enough
100%
Randomized Placebo-controlled Trial
33%
Open-label Trial
33%
Placebo-controlled Trial
33%
Clinical Effect
33%
Neuroscience
Growth Factor
100%
Glial Cell Line-Derived Neurotrophic Factor
100%
Parkinson's Disease
100%
Placebo
66%
Open-Label Trial
33%
Pharmacology, Toxicology and Pharmaceutical Science
Glial Cell Line Derived Neurotrophic Factor
100%
Parkinson's Disease
100%
Growth Factor
100%
Placebo
66%
Open-Label Trial
33%